Recruitment of liposomes as topical drug delivery systems would be promising due to their numerous advantages including enhanced skin penetration through the stratum corneum layer, skin moisturizing and restoring effects, controlled drug release, and biocompatibility and biodegradability properties (Rahimpour and Hamishehkar, 2012)
health system is whether Medicaid and Medicare are prepared to treat obesity like the chronic disease it is
Currently, common clinical GLP-1RAs include exenatide and exenatide-LAR [34,35,36,37,38,39,40], lixisenatide [41,42,43,44], beinaglutide [45], liraglutide [46,47,48,49,50,51,52,53], semaglutide [54,55,56,57,58], albiglutide [59,60,61], dulaglutide [62,63,64], oral semaglutide [58, 65,66,67], PEG-loxenatide [68] and tirzepatide [68,69,70,71,72,73] (Table 1)
4DF, S7A, B, and Supplementary Data S4)
Comprehensive testing including IGF-1, glucose, insulin, metabolic panel, and mitochondrial markers to establish baseline health status
Microorganisms 12 (9), 1747 (2024)